Literature DB >> 32274848

19 F MRI of human lungs at 0.5 Tesla using octafluorocyclobutane.

Olga S Pavlova1, Nikolay V Anisimov2, Lev L Gervits3, Mikhail V Gulyaev2, Valentina N Semenova1, Yury A Pirogov1, Vladislav Ya Panchenko1.   

Abstract

PURPOSE: The aim of this study was to demonstrate the feasibility of fluorine-19 (19 F) MRI of the human lungs using octafluorocyclobutane (OFCB, C4 F8 ). This gas has 8 magnetically equivalent fluorine nuclei and relatively long T1 and T2 (˜50 ms), which render it suitable as an MRI contrast agent. Previous experiments in small laboratory animals showed that OFCB could be successfully used as an alternative to the gases often used for 19 F MRI (sulfur hexafluoride and perfluoropropane).
METHODS: One male volunteer participated in this study. Immediately before an MRI scan, the volunteer inhaled the gas mixture-80% OFCB with 20% oxygen-and held his breath. Experiments were performed on a 0.5T whole-body MR scanner with a customized transmit-receive coil tuned at 19 F frequency. Fast spin echo in 2D and 3D modes was used for image acquisition. 2D images were obtained with in-plane resolution of 10 × 10 mm2 without slice selection. 3D images were obtained with the voxel size of 10 × 10 × 30 mm2 . Breath-hold duration was 20 s for 2D and 40 s for 3D imaging, respectively.
RESULTS: Anatomically consistent 19 F MR images of the human lungs were obtained with SNR around 50 in 2D mode and 20 in 3D mode. 3D volumetric images of the lungs were reconstructed and provided physiologically reasonable volume estimates.
CONCLUSION: The application of OFCB enables informative 19 F lung imaging even at low magnetic field strengths. The OFCB gas shows promise as an inhalable contrast agent for fluorine lung MRI and has a potential for clinical translation.
© 2020 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  19F MRI; C4F8; MRI of the human lungs; OFCB; lung imaging; octafluorocyclobutane

Mesh:

Substances:

Year:  2020        PMID: 32274848     DOI: 10.1002/mrm.28270

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  3 in total

1.  Evaluation of fluorine-19 magnetic resonance imaging of the lungs using octafluorocyclobutane in a rat model.

Authors:  Yurii Shepelytskyi; Tao Li; Vira Grynko; Camryn Newman; Francis T Hane; Mitchell S Albert
Journal:  Magn Reson Med       Date:  2020-08-12       Impact factor: 4.668

2.  Sex-Dependent Protective Effect of Combined Application of Solubilized Ubiquinol and Selenium on Monocrotaline-Induced Pulmonary Hypertension in Wistar Rats.

Authors:  Tatyana Kuropatkina; Olga Pavlova; Mikhail Gulyaev; Yury Pirogov; Anastasiya Khutorova; Sergey Stvolinsky; Natalia Medvedeva; Oleg Medvedev
Journal:  Antioxidants (Basel)       Date:  2022-03-14

3.  Multinuclear MRI Research.

Authors:  Yu A Pirogov
Journal:  Appl Magn Reson       Date:  2021-07-31       Impact factor: 0.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.